Amlodipine labels and packages: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 14: | Line 14: | ||
{| | {| | ||
| [[image: | | [[image:norvasc8.jpg|400|thumb]] | ||
|} | |} | ||
| Line 28: | Line 28: | ||
{| | {| | ||
| [[image: | | [[image:norvasc9.jpg|400px|thumb]] | ||
|} | |} | ||
Revision as of 23:09, 6 March 2014
| Amlodipine |
|---|
| NORVASC®, AMLODIPINE®, AMLODIPINE BESYLATE® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Dosage Forms and Strengths |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Amlodipine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
PRINCIPAL DISPLAY PANEL - 5 mg Tablets
Norvasc® 5 mg*
Amlodipine Besylate
10 Tablets
 |
PRINCIPAL DISPLAY PANEL - 10 mg Tablets
Norvasc® 10 mg*
Amlodipine Besylate
10 Tablets
References
- ↑ "NORVASC (AMLODIPINE BESYLATE) TABLET [CARDINAL HEALTH]". Retrieved 6 March 2014.